Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Endocrinology | Musculoskeletal | Rheumatology

Acromegaly Clinical Trials

A listing of Acromegaly medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.

Filter by:

Phase:

Gender:

Age:

Location:

 

First 1 2 Last 

California

Los Angeles California 90048

A Phase 4 clinical study for patients using Pasireotide

Los Angeles California 90048

Patients are needed to participate in a clinical research study evaluating Sandostatin LAR for the treatment of Acromegaly

Stanford California 94304

A Phase 4 clinical study for patients using Pasireotide

Maryland

NEW

Johns Hopkins University School of Medicine Division of Endocrinology, Diabetes & Metabolism
Baltimore Maryland 21287

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

Massachusetts

NEW

Massachusetts General Hospital
Boston Massachusetts 02114

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

View More ▼

Boston Massachusetts 02114

A clinical trial seeking patients for a research study for the treatment of Acromegaly

Boston Massachusetts 02114

Patients are needed to participate in a clinical research study for the treatment of Acromegaly

Michigan

NEW

University of Michigan Medical Center Rares de la Surrénale, Service d'Endocrinologie, Hôpital Cochin
Ann Arbor Michigan 48109

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

View More ▼

Ann Arbor Michigan 48109-0944

A Phase 4 clinical study for patients using Pasireotide

New Jersey

Basking Ridge New Jersey 07920

Patients are needed to participate in a clinical research study for the treatment of Acromegaly

New Mexico

NEW

University of New Mexico HSC Center Rares de la Surrénale, Service d'Endocrinologie, Hôpital Cochin
Albuquerque New Mexico 87131

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

New York

NEW

Icahn School of Medicine at Mount Sinai
New York New York 10029

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

View More ▼

New York New York 10032

A clinical research study for the treatment of Cushing's Disease, or Acromegaly

Ohio

NEW

Cleveland Clinic Endocrinology
Cleveland Ohio 44195

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

NEW

CarePoint East
Columbus Ohio 43203

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

Oregon

NEW

Oregon Health & Science University
Portland Oregon

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

Pennsylvania

NEW

University of Pennslyvania Smilow Center for Translational Research
Philadelphia Pennsylvania 19104-5160

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

Washington

Seattle Washington 98104

A Phase 4 clinical study for patients using Pasireotide

Belgium

NEW

UZLeuven Dienst endocrinologie
Leuven International

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

France

NEW

Endocrinologie, Pavillon des Ecrins Centre Hospitalier Universitaire, Hopital Nord
Cedex International

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

NEW

Hôpital de la TIMONE Department of Endocrinology and Reference Center for Rare Pituitary Diseases
Marseille International

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

NEW

Centre de Réference Maladies Rares de la Surrénale, Service d'Endocrinologie, Hôpital Cochin
Paris International 75014

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

Israel

NEW

Institute of Endocrinology & Metabolism Rabin Medical Center, Beilinson Campus
Petah Tiqva International 49100

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

Netherlands

NEW

Erasmus MC, Dpt. Of Internal Medicine, Division of Endocrinology Centre Hospitalier Universitaire, Hopital Nord
Rotterdam International

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

Spain

NEW

Hospital Universitario de la Ribera Centre Hospitalier Universitaire, Hopital Nord
Alzira-Valencia International

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

NEW

Hospital Sant Pau, Universitat Autònoma de Barcelona
Barcelona International 08025

An Open Label Study to Assess the Safety and Efficacy of COR-003 (2S, 4R ketoconazole) in the Treatment of Endogenous Cushing's Syndrome

Australia

Darlinghurst New South Wales 2010

Patients are needed to participate in a clinical research study of Somatuline Autogel® (lanreotide) 60, 90, 120 mg. to evaluate Acromegaly

Fitzroy Victoria 3065

Patients are needed to participate in a clinical research study of Somatuline Autogel® (lanreotide) 60, 90, 120 mg. to evaluate Acromegaly

Woolloongabba Queensland 4102

Patients are needed to participate in a clinical research study of Somatuline Autogel® (lanreotide) 60, 90, 120 mg. to evaluate Acromegaly

Austria

Vienna

A clinical trial to evaluate treatments using Somatuline Autogel® 60, 90 or 120 mg for patients with Acromegaly or Neuroendocrine Tumours

Belgium

Brugge 8310

A Phase 4 clinical study for patients using Pasireotide

Bruxelles 1200

A Phase 4 clinical study for patients using Pasireotide

Edegem 2650

A Phase 4 clinical study for patients using Pasireotide

Ghent 9000

A clinical research study for the treatment of Acromegaly

Leuven 3000

A Phase 4 clinical study for patients using Pasireotide

View More ▼

Liege 4000

A Phase 4 clinical study for patients using Pasireotide

Canada

Halifax Nova Scotia B3H 1V7

A Phase 4 clinical study for patients using Pasireotide

London Ontario N6A 4L6

A Phase 4 clinical study for patients using Pasireotide

Montreal H2W 1T8

A Phase 4 clinical study for patients using Pasireotide

Montreal Quebec H2L 4M1

A Phase 4 clinical study for patients using Pasireotide

Montreal Quebec H2L 4M1

Patients are needed to participate in a clinical research study evaluating Alesse for the treatment of Acromegaly

Czech Republic

Brno

A Phase 2 clinical study for patients with Active Acromegaly

Hradec Kralove

A Phase 2 clinical study for patients with Active Acromegaly

France

Angers 49033

A Phase 4 clinical study for patients using Pasireotide

Bron Cedex 69677

A Phase 4 clinical study for patients using Pasireotide

Le Kremlin Bicetre 94275

A Phase 4 clinical study for patients using Pasireotide

Pierre-Benite Cedex 69495

A Phase 4 clinical study for patients using Pasireotide

Toulouse Cedex 9 31000

A Phase 4 clinical study for patients using Pasireotide

Germany

Hamburg 20357

A clinical trial to evaluate treatments using Somatuline Autogel® 60, 90 or 120 mg for patients with Acromegaly or Neuroendocrine Tumours

Muenchen 80804

A Phase 4 clinical study for patients using Pasireotide

First 1 2 Last 

Receive E-mails About New Clinical Trials!

Sign up for our FREE service and we'll send you automatic email notifications as soon as a clinical trial is posted in the medical category you're interested in.